JP2001524828A5 - - Google Patents

Download PDF

Info

Publication number
JP2001524828A5
JP2001524828A5 JP1998547062A JP54706298A JP2001524828A5 JP 2001524828 A5 JP2001524828 A5 JP 2001524828A5 JP 1998547062 A JP1998547062 A JP 1998547062A JP 54706298 A JP54706298 A JP 54706298A JP 2001524828 A5 JP2001524828 A5 JP 2001524828A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998547062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/007801 external-priority patent/WO1998049300A2/en
Publication of JP2001524828A publication Critical patent/JP2001524828A/ja
Publication of JP2001524828A5 publication Critical patent/JP2001524828A5/ja
Ceased legal-status Critical Current

Links

JP54706298A 1997-04-25 1998-04-20 切断型ｖｅｇｆ関連蛋白質 Ceased JP2001524828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84298497A 1997-04-25 1997-04-25
US08/842,984 1997-04-25
PCT/US1998/007801 WO1998049300A2 (en) 1997-04-25 1998-04-20 Truncated vegf-related proteins

Publications (2)

Publication Number Publication Date
JP2001524828A JP2001524828A (ja) 2001-12-04
JP2001524828A5 true JP2001524828A5 (zh) 2005-12-02

Family

ID=25288752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54706298A Ceased JP2001524828A (ja) 1997-04-25 1998-04-20 切断型ｖｅｇｆ関連蛋白質

Country Status (10)

Country Link
EP (1) EP0977854A2 (zh)
JP (1) JP2001524828A (zh)
KR (1) KR20010020259A (zh)
CN (2) CN1260835A (zh)
AU (1) AU7250298A (zh)
CA (1) CA2287538A1 (zh)
EA (1) EA199900861A1 (zh)
IL (1) IL132537A0 (zh)
NZ (2) NZ514872A (zh)
WO (1) WO1998049300A2 (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0751992T3 (da) 1994-03-08 2006-03-06 Human Genome Sciences Inc Karendotelvækstfaktor 2
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6040157A (en) * 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
ES2202469T5 (es) 1995-09-08 2011-06-06 Genentech, Inc. Proteína relacionada con el vegf.
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
CN1299407A (zh) * 1998-03-13 2001-06-13 人体基因组科学有限公司 血管内皮生长因子2
WO1999049882A2 (en) * 1998-03-27 1999-10-07 Eicher Dorothea J Vegf and vegf-c as infant formula supplements
DE19813774A1 (de) * 1998-03-27 1999-09-30 Max Planck Gesellschaft Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
EP1109823B1 (en) 1998-09-08 2005-11-16 Agouron Pharmaceuticals, Inc. Modifications of the vegf receptor-2 protein and methods of use
US6958147B1 (en) 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
ES2229788T3 (es) * 1998-10-26 2005-04-16 Ludwig Institute For Cancer Research Uso del gen o proteina vegf-c o vegf-d para prevenir la restenosis.
EP1568375A1 (en) * 1998-10-26 2005-08-31 Ludwig Institute For Cancer Research Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
ATE406907T1 (de) 1998-10-28 2008-09-15 Cornell Res Foundation Inc Methoden zur regulierung der angiogenese und vaskuläre integrität mittels trk rezeptor liganden bdnf, nt-3 und nt-4
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
AU4643501A (en) * 2000-02-04 2001-08-14 Flanders Interuniversity Institute For Biotechnology (Vib) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
US7727971B2 (en) 2000-02-04 2010-06-01 Life Sciences Research Partners Vzw Use of placental growth factor for treating ischemic muscle disease
EP1604024A4 (en) 2000-04-06 2008-04-23 Wayne P Franco METHODS OF USING GROWTH FACTORS FOR TREATING CARDIOPATHY
EP1157999A1 (en) * 2000-05-24 2001-11-28 Introgene B.V. Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
AU8473401A (en) 2000-08-04 2002-02-18 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7405278B2 (en) 2000-08-10 2008-07-29 Masabumi Shibuya Chimeric human-type vascular endothelial cell growth factor
EP1191104A1 (en) * 2000-09-26 2002-03-27 Introgene B.V. Gene delivery vehicles and use thereof in the preparation of a medicament and/or vaccine
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
AU2884102A (en) 2000-12-07 2002-06-18 Sangamo Biosciences Inc Regulation of angiogenesis with zinc finger proteins
DE60236646D1 (de) 2001-04-13 2010-07-22 Human Genome Sciences Inc Anti-VEGF-2 Antikörper
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
JP2005505510A (ja) * 2001-06-20 2005-02-24 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｖｅｇｆ−ｂによる血管新生の刺激
KR100967599B1 (ko) 2001-10-15 2010-07-05 얀센 파마슈티카 엔.브이. 허혈성 손상을 감소시키기 위한 치환된4-페닐-4-(1ｈ-이미다졸-2-일)-피페리딘 유도체
EP1827494A4 (en) * 2004-11-18 2010-02-17 Wayne Franco COMBINATION GROWTH THERAPY AND CELL THERAPY FOR THE TREATMENT OF ACUTE AND CHRONIC ORGANIC DISEASES
EP2385840A4 (en) * 2009-01-07 2012-12-12 Vegenics Pty Ltd MATERIALS AND METHOD FOR TREATING BLOOD HIGH PRESSURE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1242149B (it) * 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
DE69331526T2 (de) * 1992-11-18 2002-10-24 Arch Dev Corp Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
US6645933B1 (en) * 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
JP3961019B2 (ja) * 1995-02-28 2007-08-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 遺伝子転移媒介の血管形成療法
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
EP0815221B1 (en) * 1995-03-02 2003-10-22 AMRAD Operations Pty.,Ltd. A novel growth factor and a genetic sequence encoding same
CA2224002A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human vascular endothelial growth factor 3

Similar Documents

Publication Publication Date Title
JP2000509637A5 (zh)
JP2000509942A5 (zh)
JP2000510751A5 (zh)
JP2000507042A5 (zh)
JP2000509635A5 (zh)
JP2001519020A5 (zh)
JP2002510247A5 (zh)
JP2000507433A5 (zh)
JP2000509587A5 (zh)
JP2000507369A5 (zh)
JP2000508866A5 (zh)
JP2000510793A5 (zh)
JP2000508022A5 (zh)
JP2000508841A5 (zh)
JP2001524828A5 (zh)
JP2000508680A5 (zh)
JP2000509804A5 (zh)
JP2000510969A5 (zh)
JP2000509755A5 (zh)
JP2000508836A5 (zh)
JP2000509520A5 (zh)
JP2000510247A5 (zh)
JP2000509818A5 (zh)
JP2001511709A5 (zh)
JP2000507434A5 (zh)